The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients
Abstract Background One of the crucial functions of the immune system is to prevent tumorigenesis, yet cancer occurs when malignant cells manage to evade immune surveillance via multiple strategies. Accordingly, this study aimed at assessing the potential significance of the novel immune checkpoint...
Main Authors: | Sara M. Radwan, Nooran S. Elleboudy, Nermeen A. Nabih, Amal El-kholy, Amany M. Kamal |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-10-01
|
Series: | Egyptian Journal of Medical Human Genetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43042-021-00198-1 |
Similar Items
-
BTLA biology in cancer: from bench discoveries to clinical potentials
by: Anna Andrzejczak, et al.
Published: (2024-01-01) -
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
by: John Choi, et al.
Published: (2021-01-01) -
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia
by: Christian Sordo-Bahamonde, et al.
Published: (2021-04-01) -
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
by: Yu-Li Chen, et al.
Published: (2019-11-01) -
BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation – design, synthesis and biological evaluation
by: Katarzyna Kuncewicz, et al.
Published: (2023-09-01)